J Mark Christensen
Overview
Explore the profile of J Mark Christensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kottwitz J, Bechert U, Cruz-Espindola C, Christensen J, Boothe D
J Zoo Wildl Med
. 2024 Mar;
55(1):73-85.
PMID: 38453490
Firocoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID) with limited effects on COX-1, which means it likely has fewer side effects than typically associated with other NSAIDs. This study determined...
2.
Kottwitz J, Bechert U, Cruz-Espindola C, Christensen J, Boothe D
J Zoo Wildl Med
. 2023 Jul;
54(2):350-359.
PMID: 37428699
The time course of serum firocoxib concentrations was described after administration of two single oral doses (0.01 and 0.1 mg/kg) of commercially available firocoxib tablet ( = 4) and paste...
3.
LeBlanc N, Scollan K, Mohamed S, Christensen J
Am J Vet Res
. 2021 Sep;
82(10):811-817.
PMID: 34554869
Objective: To investigate associations between short-term treatment with a previously described compounded transdermal formulation of atenolol and heart rate in cats. Animals: 11 healthy adult cats. Procedures: Cats received the...
4.
Bechert U, Christensen J, Kottwitz J, Boothe D, Alshahrani S, Mohammed S
J Zoo Wildl Med
. 2021 Jan;
51(4):905-914.
PMID: 33480571
Flunixin meglumine is the most commonly used nonsteroidal anti-inflammatory drug used to treat elephants; however, no pharmacokinetic study for flunixin has yet been conducted in these species, and dosages used...
5.
Huston R, Christensen J, Alshahrani S, Mohamed S, Heisel C, Stout K
JPEN J Parenter Enteral Nutr
. 2018 Aug;
43(3):426-433.
PMID: 30156306
Background: Parenteral nutrition (PN) solutions containing calcium gluconate (CaGlu) and cysteine have elevated particle counts when analyzed using laser light obscuration (LO) as recommended by the United States Pharmacopeia (USP)....
6.
Huston R, Heisel C, Vermillion B, Christensen J, Minc L
Nutr Clin Pract
. 2018 Jun;
32(2):266-270.
PMID: 29927528
Introduction: Calcium chloride (CaCl ) has been the only calcium additive available in the United States that has a low aluminum (Al) content. Calcium gluconate in glass vials (CaGluc-Gl) has...
7.
Huston R, Christensen J, Alsharhani S, Mohamed S, Heisel C
Nutrients
. 2018 Feb;
10(2).
PMID: 29443921
There are no compatibility studies for neonatal parenteral nutrition solutions without cysteine containing calcium chloride or calcium gluconate using light obscuration as recommended by the United States Pharmacopeia (USP). The...
8.
OConnor A, Konda V, Reed R, Christensen J, Stevens J, Contractor N
Mol Nutr Food Res
. 2018 Jan;
62(6):e1700692.
PMID: 29322620
Scope: Xanthohumol (XN), a prenylated flavonoid found in hops, exhibits anti-inflammatory and antioxidant properties. However, poor bioavailability may limit therapeutic applications. As food components are known to modulate polyphenol absorption,...
9.
Huston R, Heisel C, Vermillion B, Christensen J, Minc L
Nutr Clin Pract
. 2016 Sep;
32(2):266-270.
PMID: 27679526
Introduction: Calcium chloride (CaCl) has been the only calcium additive available in the United States that has a low aluminum (Al) content. Calcium gluconate in glass vials (CaGluc-Gl) has a...
10.
Huston R, Christensen J, Alshahrani S, Mohamed S, Clark S, Nason J, et al.
PLoS One
. 2015 Aug;
10(8):e0136894.
PMID: 26317344
Background: Previous studies of compatibility of calcium chloride (CaCl2) and phosphates have not included particle counts in the range specified by the United States Pharmacopeia. Micro-flow imaging techniques have been...